Caregiver Burden and Distress in Hematopoeitic Stem Cell Transplant
NCT ID: NCT01084694
Last Updated: 2020-01-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2010-04-19
2018-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients
NCT00082654
Physical and Emotional Health of Caregivers for People Who Have Had Stem Cell Transplants
NCT01468857
Psychological Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation (HCT)
NCT03042715
Education Program to Manage Emotional Stress of Stem Cell Transplant Recipients and Their Caregivers
NCT00423774
Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant
NCT00004994
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any patient undergoing autologous or allogeneic HSCT at The Blood and Marrow Transplant Program at Northside Hospital
* Patients must have a single primary caregiver
* Patients must be willing to comply with all assessments as outlined in the protocol
* Patients must be willing to sign informed consent
Caregiver:
* Must be the primary caregiver for an autologous or allogenic HSCT patient at the Blood and Marrow Transplant Program at Northside Hospital
* Caregiver must be willing to comply will all assessments as outlined in the protocol
* Caregiver must be willing to sign consent
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northside Hospital, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dawn Speckhart, PhD
Role: PRINCIPAL_INVESTIGATOR
Northside Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northside Hospital
Atlanta, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NSH 888
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.